| Literature DB >> 18062820 |
Jörg Martin1, Martin Franck, Stefan Sigel, Manfred Weiss, Claudia Spies.
Abstract
BACKGROUND: The aim of this study, conducted in 2006, was to find out whether changes in sedation management in German intensive care units took place in comparison with our survey from 2002.Entities:
Mesh:
Substances:
Year: 2007 PMID: 18062820 PMCID: PMC2246220 DOI: 10.1186/cc6189
Source DB: PubMed Journal: Crit Care ISSN: 1364-8535 Impact factor: 9.097
General data of the surveyed intensive care units in 2002 and 2006
| 2002 Median (minimum, maximum) | 2006 Median (minimum, maximum) | ||
| Intensive care beds (university hospitals) | 14 (8, 24) | 24 (10, 32) | 0.09 |
| Intensive care beds (general hospitals) | 9 (2, 27) | 10 (4, 40) | 0.02 |
| Patients per year (university hospitals) | 1,481 (517, 2,500) | 2,000 (700, 2,860) | 0.2 |
| Patients per year (general hospitals) | 930 (120, 5,297) | 1,000 (120, 4,578) | 0.03 |
| Nursing care days (university hospitals) | 4,950 (2,000, 7,900) | 5,000 (3,000, 13,900) | 0.5 |
| Nursing care days (general hospitals) | 2,704 (400, 7,830) | 3,000 (250, 15,462) | 0.06 |
The Mann-Whitney U test was used to calculate p values.
Sedation practices in 2002 and 2006
| 2002 ( | 2006 ( | ||
| Percentage (95% CI) | |||
| Sedation score | 8 (-4 to 20) | 51 (41 to 60) | <0.001 |
| Sedation protocol | 21 (9 to 32) | 46 (36 to 56) | <0.001 |
| Medication selection according to sedation duration | 92 (88 to 96) | 93 (89 to 97) | 0.5 |
| Oral procedure instructions | 44 (33 to 53) | 93 (89 to 97) | <0.001 |
| Day-night rhythm | 81 (75 to 87) | 88 (84 to 94) | <0.001 |
| Consideration of costs affecting drug selection | 62 (54 to 70) | 55 (46 to 64) | 0.4 |
The chi-square test was used to calculate p values. CI, confidence interval; n, number of positive answers.
Reasons given for changes in sedation management since the last survey (2002)
| Changes in sedation management | Percentage (95% CI) |
| Resulting from S2e guidelines | 29 (18 to 40) |
| Resulting from change in department leadership | 10 (-3 to 23) |
| Following lectures | 32 (21 to 42) |
| Following literature | 46 (36 to 56) |
| Other | 13 (-6 to 32) |
CI, confidence interval; n, number of positive answers.
Changes accomplished in sedation management since 2002
| Changes | Percentage (95% CI) |
| Sedatives changed | 33 (22 to 44) |
| Analgesia changed | 31 (20 to 42) |
| Regional techniques introduced | 19 (7 to 31) |
| Pain scoring introduced | 21 (9 to 33) |
| Daily sedation break | 34 (23 to 45) |
| Sedation protocol implemented | 23 (11 to 35) |
| Other | 4 (-9 to 17) |
CI, confidence interval; n, number of positive answers.
Comparison of the techniques and agents used for analgesia and sedation in 2002 and 2006
| Less than 24 hours | 24 to 72 hours | |||||
| Percentage (95% CI) | Percentage (95% CI) | |||||
| Year | 2002 | 2006 | 2002 | 2006 | ||
| Midazolam | 45.9 (36.1 to 55.6) | 34.6 (23.7 to 45.4) | <0.001 | 77.3 (71.0 to 83.6) | 62.2 (53.9 to 70.4) | <0.001 |
| Propofol | 81.4 (75.7 to 87.1) | 82.7 (77.1 to 88.3) | 0.6 | 55,9 (47.2 to 64.7) | 67.3 (59.6 to 74.9) | <0.001 |
| Remifentanil | 5.9 (-6.9 to 18.7) | 16.8 (4.6 to 29.0) | <0.001 | 2.3 (-10.8 to 15.3) | 7.9 (-4.9 to 20.8) | <0.002 |
| Fentanyl | 40.0 (29.8 to 50.3) | 27.1 (15.7 to 38.5) | <0.001 | 55.9 (47.1 to 64.7) | 40.7 (30.3 to 51.0) | <0.001 |
| Sufentanil | 35.0 (24.4 to 45.7) | 41.6 (31.4 to 51.8) | <0.05 | 47.7 (38.2 to 57.3) | 58.4 (49.8 to 67.1) | <0.002 |
| Piritramide | 38.2 (27.8 to 48.6) | 35.1 (24.3 to 45.8) | 0.3 | 15.5 (3.3 to 27.6) | 16.8 (4.6 to 29.0) | 0.6 |
| Morphine | 8.6 (-4.0 to 21.3) | 7.5 (-5.4 to 20.4) | 0.5 | 4.5 (-8.4 to 17.5) | 7.9 (-4.9 to 20.8) | 0.06 |
| PCA | 25.5 (14.0 to 36.9) | 28.5 (17.2 to 39.8) | 0.3 | 15.5 (3.3 to 27.6) | 21.5 (9.6 to 33.4) | <0.001 |
| Ketamine (S) | 6.8 (-5.9 to 19.6) | 14.5 (2.1 to 26.9) | 0.001 | 20.0 (8.2 to 31.8) | 25.7 (14.2 to 37.2) | <0.001 |
| Clonidine | 35.9 (25.3 to 46.5) | 33.6 (22.7 to 44.6) | 0.5 | 48.2 (38.7 to 57.7) | 49.5 (40.0 to 59.1) | 0.7 |
| NSAIDs | 26.8 (15.6 to 38.2) | 23.8 (12.1 to 35.5) | 0.3 | 13.2 (0.8 to 25.5) | 16.8 (4.6 to 29.0) | 0.1 |
| NMBAs | 3.6 (-9.3 to 16.6) | 0.0 | 0.5 | 0.0 | 0.0 | n.c. |
| PNB | 15.5 (3.3 to 27.6) | 23.8 (12.1 to 35.5) | 0.004 | 12.7 (0.4 to 25.1) | 22.0 (10.1 to 33.8) | <0.001 |
| PCEA | 7.3 (-5.5 to 20.0) | 11.7 (-0.9 to 24.3) | 0.04 | 5.9 (-6.9 to 18.7) | 9.8 (-2.9 to 22.5) | 0.05 |
| Epidural | 68.2 (60.8 to 75.7) | 72.0 (64.9 to 79.1) | 0.5 | 59.1 (50.7 to 67.6) | 73.8 (67.0 to 80.7) | <0.001 |
The chi-square test was used to calculate p values. CI, confidence interval; n, number of positive answers; n.c., not calculated; NMBAs, neuromuscular blocking agents; NSAIDs, non-steroidal anti-inflammatory drugs; PCA, patient-controlled analgesia; PCEA, patient-controlled epidural analgesia; PNB, peripheral nerve block.
Comparison of the techniques and agents used for analgesia and sedation in 2002 and 2006
| More than 72 hours | Weaning | |||||
| Percentage (95% CI) | Percentage (95% CI) | |||||
| Year | 2002 | 2006 | 2002 | 2006 | ||
| Midazolam | 90.5 (86.4 to 94.5) | 92.1 (88.3 to 95.8) | 0.4 | 34.1 (23.4 to 44.8) | 32.2 (21.2 to 43.3) | 0.06 |
| Propofol | 26.4 (15.0 to 37.7) | 22.9 (11.1 to 34.7) | 0.2 | 72.3 (65.3 to 79.3) | 75.2 (68.6 to 81.9) | 0.3 |
| Remifentanil | 1.4 (-11.8 to 14.5) | 3.7 (-9.4 to 16.9) | 0.06 | 5.9 (-6.9 to 18.7) | 15.0 (2.6 to 27.3) | <0.001 |
| Fentanyl | 65.0 (57.2 to 72.8) | 53.7 (44.6 to 62.9) | <0.001 | 30.0 (19.0 to 41.0) | 21.5 (9.6 to 33.4) | 0.002 |
| Sufentanil | 43.6 (33.7 to 3.5) | 51.4 (42.1 to 0.7) | 0.02 | 41.8 (31.8 to 51.9) | 49.5 (40.0 to 9.1) | 0.02 |
| Piritramide | 9.1 (-3.5 to 21.7) | 7.9 (-4.9 to 20.8) | 0.5 | 25.5 (14.1 to 36.9) | 24.3 (12.6 to 36.0) | 0.7 |
| Morphine | 7.3 (-5.5 to 20.0) | 9.8 (-2.9 to 22.5) | 0.2 | 8.6 (-4.0 to 21.3) | 9.4 (-3.4 to 22.1) | 0.7 |
| PCA | 9.5 (-3.0 to 22.1) | 7.0 (-5.9 to 19.9) | 0.5 | (-0.1 to 24.7) | 12.2 (-0.4 to 24.7) | 0.9 |
| Ketamine (S) | 19.1 (13.6 to 36.4) | 19.6 (7.6 to 31.6) | 0.7 | 5.0 (-7.9 to 17.9) | 4.2 (-8.9 to 17.3) | 0.7 |
| Clonidine | 56.4 (47.7 to 65.1) | 52.8 (43.6 to 62.0) | 0.3 | 62.7 (54.6 to 70.8) | 58.9 (50.3 to 67.5) | 0.5 |
| NSAIDs | 10.5 (-2.1 to 23.0) | 10.3 (-2.4 to 22.9) | 0.9 | 14.1 (1.8 to 26.3) | 19.2 (7.1 to 31.2) | 0.06 |
| NMBAs | 0.0 | n.c. | n.c. | 0.0 | n.c. | n.c. |
| PNB | 10.0 (-2.5 to 22.5) | 14.5 (2.1 to 26.9) | 0.6 | 7.7 (-5.0 to 20.4) | 13.6 (1.1 to 26.0) | 0.01 |
| PCEA | 4.1 (-8.9 to 17.0) | 3.7 (-9.4 to 16.9) | 0.8 | 4.6 (-8.4 to 17.5) | 5.6 (-7.4 to 18.6) | 0.5 |
| Epidural | 45.9 (36.2 to 5.6) | 56.5 (47.7 to 5.4) | <0.005 | 42.3 (32.2 to 52.3) | 52.8 (43.6 to 62.0) | <0.005 |
The chi-square test was used to calculate p values. CI, confidence interval; n, number of positive answers; n.c., not calculated; NMBAs, neuromuscular blocking agents; NSAIDs, non-steroidal anti-inflammatory drugs; PCA, patient-controlled analgesia; PCEA, patient-controlled epidural analgesia; PNB, peripheral nerve block.